Overview
Oxylabs sells access to proxy infrastructure across two product lines on record: a residential proxy network and a Web Scraper API. The residential line is billed by data volume, while the scraper API is billed as a monthly subscription, reflecting two different ways of charging for what is, broadly, IP access and data-retrieval tooling. The provider documents coverage across 200 countries in its product listing, alongside a separate, provider-stated figure of “188+ countries” attached to its specifications sheet. Both figures come from the provider; this directory has not independently verified either, and buyers who need coverage in a specific country should confirm it directly before committing.
What the record shows
Oxylabs documents a network spanning residential, mobile, ISP and datacentre IPs, with a stated pool of 175M+ residential, 20M+ mobile and 2M+ datacentre addresses. It advertises rotating and sticky session options, targeting by country, city and ASN, and support for HTTP, HTTPS and SOCKS5 protocols. Authentication is documented as username/password or IP allowlist, and the provider states that concurrency is unlimited. A web dashboard with usage statistics is listed, along with 24/7 support and an “ethically sourced” claim for its IP network — a description the provider applies to itself rather than one this directory can confirm. The provider also states a high success-rate claim for its network, but the specific figure is a provider-supplied marketing metric rather than a result of any test conducted here, so it is not repeated as a fact in this review; buyers who want a performance figure they can rely on should ask Oxylabs directly for the basis of that claim and test it against their own traffic. Payment is documented as cards, wire transfer in USD or EUR, AliPay and PayPal, with Bitcoin explicitly excluded. A free trial of five datacentre IPs is offered, though the provider has not detailed the trial's terms, so questions like duration, renewal and whether it converts automatically to a paid plan are worth raising before signing up. No founding date, office location or named customers are on record, and none are stated here.
Pricing
The Residential Proxies entry plan is listed at USD 6 per GB, meaning cost scales with data transferred rather than with time or number of IPs — a model that suits variable or bursty usage but can become expensive at high volumes if not monitored. The Web Scraper API entry plan is listed separately at USD 49 per month, a flat subscription unrelated to data volume, so the two prices are not directly comparable as numbers; a buyer weighing them needs to think in terms of GB consumed versus a fixed monthly allowance instead. On the per-GB metric, this directory records Oxylabs as cheaper than only 5% of the 21 providers here that also bill by the gigabyte, placing the entry residential price toward the upper end of what is recorded elsewhere in this directory.
Who it suits
Based on the recorded specifications, this looks suited to teams that need broad protocol support (HTTP, HTTPS, SOCKS5), flexible session handling, and city- or ASN-level targeting for scraping or data-collection work, and who are comfortable paying by volume rather than by fixed allowance. The separate Web Scraper API may appeal to teams that want a packaged scraping tool rather than raw proxy access, provided the fixed monthly cost fits their usage pattern. It is less obviously suited to cost-sensitive buyers doing high-volume, continuous data pulls, given the per-GB entry price sits above most recorded competitors here, nor to anyone who needs an independently verified uptime or success-rate figure before purchasing, since none exists on this record yet.
Where to look closer
Buyers should ask Oxylabs directly about the terms attached to the five free datacentre IPs, including duration and what happens once the trial ends. It is worth clarifying which country count is current — the 200 figure or the “188+” figure — and asking for a breakdown by country rather than a single headline number. The provider's success-rate and “ethically sourced” claims are stated by Oxylabs itself; ask what evidence sits behind them and whether independent audits exist. Finally, since no controlled performance testing has been published by this directory, prospective customers should run their own trial against real target sites before committing to volume-based billing at scale.
This assessment is editorial analysis of the sourced facts recorded on this page. Specifications, pricing and coverage are provider-stated and dated in the panels above. No controlled performance test has been run against this provider.
